Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

The Clinical Frailty Scale can indicate prognosis and care requirements on discharge in oncology and haemato‐oncology inpatients: A cohort study

The Clinical Frailty Scale can indicate prognosis and care requirements on discharge in oncology... What is already known about the topicThe Eastern Cooperative Oncology Group Performance Status Scale is a 40‐year‐old adaption of the Karnofsky Performance Status Scale, produced to assess oncology patients' suitability for treatments and clinical trials.The Eastern Cooperative Oncology Group Performance Status Scale has limited ability to account for multimorbidity, frailty and cognition and reflect changes in patients' condition. Patients may therefore inappropriately receive or not receive systemic therapy.Patient safety initiatives have recommended the use of the Rockwood CFS; however, there is limited evidence for its use in an oncology setting.What this paper addsIncreasing frailty measured using the CFS is associated with poor prognosis in adult oncology and haemato‐oncology inpatients at any age.Implications for practice, theory or policyThis paper supports use of the CFS in the oncology setting in patients of all age groups.Further evaluation is required to establish if measuring frailty can enable early conversations about discharge planning.INTRODUCTIONIn oncology, functional ability is used to assess suitability for treatment. The primary tool for evaluation is the Eastern Co‐operative Oncology Group Performance Status Scale (ECOG PS). However, this scale has been criticised as subjective and prone to bias particularly in the older patient population (Simcock & Wright, 2020) with limited ability to http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png European Journal of Cancer Care Wiley

The Clinical Frailty Scale can indicate prognosis and care requirements on discharge in oncology and haemato‐oncology inpatients: A cohort study

Download PDF
9 pages

Loading next page...
 
/lp/wiley/the-clinical-frailty-scale-can-indicate-prognosis-and-care-rpHrsGkzUE

References (32)

Publisher
Wiley
Copyright
© 2022 John Wiley & Sons Ltd
ISSN
0961-5423
eISSN
1365-2354
DOI
10.1111/ecc.13752
Publisher site
See Article on Publisher Site

Abstract

What is already known about the topicThe Eastern Cooperative Oncology Group Performance Status Scale is a 40‐year‐old adaption of the Karnofsky Performance Status Scale, produced to assess oncology patients' suitability for treatments and clinical trials.The Eastern Cooperative Oncology Group Performance Status Scale has limited ability to account for multimorbidity, frailty and cognition and reflect changes in patients' condition. Patients may therefore inappropriately receive or not receive systemic therapy.Patient safety initiatives have recommended the use of the Rockwood CFS; however, there is limited evidence for its use in an oncology setting.What this paper addsIncreasing frailty measured using the CFS is associated with poor prognosis in adult oncology and haemato‐oncology inpatients at any age.Implications for practice, theory or policyThis paper supports use of the CFS in the oncology setting in patients of all age groups.Further evaluation is required to establish if measuring frailty can enable early conversations about discharge planning.INTRODUCTIONIn oncology, functional ability is used to assess suitability for treatment. The primary tool for evaluation is the Eastern Co‐operative Oncology Group Performance Status Scale (ECOG PS). However, this scale has been criticised as subjective and prone to bias particularly in the older patient population (Simcock & Wright, 2020) with limited ability to

Journal

European Journal of Cancer Care – Wiley

Published: Nov 1, 2022

Keywords: allied health personnel; cancer; frailty; palliative care; patient discharge; prognosis

There are no references for this article.